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Abstract 
 
 
This thesis describes the development of novel catalytic oxidation and reduction reactions. 
More specifically, the synthesis of alcohols, aldehydes, epoxides, ketones, quinones has 
been developed based on Fe, Re, Ru, and Zn catalysts. In general, the described oxidations 
as well as reduction reactions provided high reactivity and good to excellent selectivity. In 
addition to catalytic studies mechanistic investigations were also performed. A major focus 
of the work has been on the synthesis of quinones, whereby excellent results in catalysis 
were realized. 
 
 
 
Zusammenfassung 
 
 
Die vorliegende Dissertation beschäftigt sich mit der Entwicklung neuer katalytischer 
Oxidations- und Reduktionsmethoden. In diesem Rahmen wurden verschiedene Alkohole, 
Aldehyde, Epoxide, Ketone und Chinone in Gegenwart von Fe, Re, Ru, Zn Katalysatoren 
synthetisiert. Die beschriebenen Oxidations- als auch die Reduktionsreaktionen führten zu 
sehr guten Umsätzen und Selektivitäten. Neben katalytischen Studien wurden auch 
mechanistische Untersuchungen erfolgreich durchgeführt. Der Schwerpunkt dieser Arbeit 
lag jedoch auf der Synthese von Chinonen, wobei sehr gute Ergebnisse in der Katalyse 
realisiert wurden.  
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Oxygenated compounds are of major scientific and technical importance. In addition, they 
play also an important role in everyday life. In organic chemistry oxygen is one of the most 
important elements beside carbon, hydrogen and nitrogen. It forms a variety of important 
functional groups, with carbon-oxygen single or double bonds (carbonyl group). Scheme 1 
presents some important organic compounds which include C-O and / or C=O bounds.  
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Scheme 1: Some important organic compounds with C-O bond or carbonyl group. 
 
The simplest carbon-oxygen single bond compounds are alcohols, which have a hydroxy 
group. Therefore they are derivates of water and it is possible to act as acid (proton 
donator) or base (proton acceptor) like water. After changing one hydrogen atom against a 
carbon group it becomes ether (Figure 1).[1]  
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O
HH
water
O
HH3C
methanol
O
CH3H3C
dimethylether  
Figure 1: Structure of water, methanol and dimethylether. 
 
Cyclic ethers with three ring atoms are named oxiranes (epoxides, Figure 2). This ring 
approximately forms an equilateral triangle, which makes it highly strained. The strained 
ring makes epoxides more reactive than other ethers. The industrially dominant epoxides 
are ethylene oxide and propylene oxide.[2] 
R2
O
R4
R1 R3
 
Figure 2: Epoxide. 
 
Alcohols are distributed ubiquitous in nature and are used for numerous applications 
(isopropanol: production of acetone, glycol: anti-freezing agent, and so on). Ethanol is used 
as "drinking alcohol" since millennia and can be produced from carbohydrates by natural 
fermentation (Scheme 2).[3]  
C6H12O6 2 CH3CH2OH + 2 CO2leaven  
Scheme 2: Manufacturing of ethanol by natural fermentation. 
 
Alcohols are used e.g. as solvents and the technical production of simple aliphatic alcohols 
(mainly methanol) proceeds from synthesis gas (CO and H2) (Scheme 3).[1] 
CO + 2 H2
2 CO + 3 H2
CH3OH
Cu-ZnO-Cr2O, 250 °C, 5-10 MPa
Rn or Ru, pressure, heat
H2C CH2
OH OH  
Scheme 3: Synthesis of methanol or ethylene glycol using synthesis gas and different catalysts. 
 
Aromatic alcohols are known as phenols. The syntheses of phenols are quite different 
compared to the synthesis of aliphatic alcohols. The most common industrial production 
of phenol is the cumene process (Hock process) (Scheme 4).[2,4] 
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O2
O
OH
O
O
10% H2SO4, H2O, heatH+, heat
cumene cumenehydroperoxide acetone phenole  
Scheme 4: Cumene process.  
 
Substituted phenols are applied in medicine (topical anaesthetic, ear drops, scelerosing 
agent or neurolytic agent), as herbicides and as industrial intermediates (bisphenol A, 
caprolactam). Oxidation of phenols is the most common method to obtain quinones 
(Scheme 5), which are involved in important oxidation-reduction processes in nature 
(photosynthesis, respiration chain, and so on).  
HO
OH
O
O
K2Cr2O7, H2SO4
1,4-benzenediol
(hydroquinone)
p-benzoquinone
OH OAg2O, MgSO4
-Ag, H2O
1,2-benzenediol
(catechol)
o-benzoquinone
OH O
 
Scheme 5: Synthesis of o - and p-benzoquinone.  
 
Aldehydes and ketones are most common carbonyl compounds which are used as flavour 
and aroma chemicals for the food industry.[5] Formaldehyde and acetone, are produced on 
million ton scale and used for various bulk applications. The former one is industrially 
produced by oxidation of methanol and used for phenolic resins production or as 
bactericidal or fungicidal disinfectant as an aqueous solution (formalin).[6] Acetone is a side 
product of the cumene process (vide supra, Scheme 4) and is used as solvent and in the 
chemical industry as raw material for other compounds. Table 1 summarizes four options 
for laboratory-scale synthesis of aldehydes or ketones.[6] 
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Table 1: Synthesis of aldehydes and ketones. 
 
Reaction Formula 
1. oxidation of alcohols 
CH2OH
PCC, CH2Cl2
CH
O
 
2. ozonolysis of alkenes C C
1. O3, CH2Cl2
2. (CH3)2S C O CO
3. hydration of alkynes 
C C
H2O, H+, Hg2+ C
O H2
C  
4. Friedel-Crafts-Alkylation 
1. RCOCl, AlCl3, CS2
2. H+, H2O R
O
 
 
The combination of a single and double carbon-oxygen in one carbon atom is called 
carboxylic acid group and is shown in Figure 3.  
 
Figure 3: Carboxylic acid. 
 
The two simplest acids are formic acid and acetic acid. Both are synthesized on a large 
industrial scale.[7] The former is used for the tanning of leather and in the manufacture of 
latex.[8] It is produced by powdered sodium hydroxide with carbon monoxide under high 
pressure at 150 °C (Scheme 6).[9]  
NaOH + CO HCOO-Na+ HCOOH
150 °C, 700-800 kPa H+, H2O
 
Scheme 6: Synthesis of formic acid. 
 
In nature acetic acid is formed via enzymatic oxidation of ethanol. The acetic acid and 
anhydride are industrially important chemicals, which are used for production of 
monomers for the polymerization. Additionally, they are used as precursors in the synthesis 
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of pharmaceuticals, dyes and pesticides. The industrial processes used for production are 
oxidation of ethene, oxidation of butane and carbonylation of methanol (Scheme 7).[9] 
H2C CH2
O2, H2O, PdCl2/CuCl2
Wacker process
CH3CHO
O2, [Co3+] CH3COOH
oxidation of ethene
CH3CH2CH2CH3
O2, [Co3+], 1500-2000 kPa, 180 °C CH3COOH
oxidation of butane
CH3OH
CO, [Rh3+], 3000-4000 kPa, 180 °C
Monsanto process
CH3COOH
carbonylation of methanol
 
Scheme 7: Synthesis of acetic acid.  
 
Important carboxylic acid derivatives are amides and esters. They are widely distributed in 
nature (fat, oils, beeswax) and have many practical applications (e.g. PET, PVC, insecticide, 
medicines and so on). The formation of esters proceeds by reaction of carboxylic acids and 
alcohols under acid-catalyzed conditions (Scheme 8).[10]  
CH3COH
O
CH3OH
H2SO4, heat
- H2O CH3COCH3
O
methylacetate  
Scheme 8: Synthesis of esters. 
 
In the same way amides can be produced by reaction of carboxylic acids and amines 
instead of the alcohol, whereby an addition-elimination reaction takes place (Scheme 9).[11]  
CH3COH
O
(CH3)2NH
155 °C
- H2O CH3CN(CH3)2
O
N,N-dimethylacetamid  
Scheme 9: Synthesis of amides.
 
The amide structure can be found in many natural materials including peptides, which are 
regarded as an important class of compound in nature.  
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The present dissertation highlights recent achievements in metal-catalyzed (Fe, Re, Ru, Zn) 
oxidation and reduction reactions to several oxygenated compounds. Thereby quinones, 
aldehydes, ketones, epoxides, and alcohols were synthesized with different catalytic 
reactions. The main focus of the work is set on the class of quinones. For this reason in the 
next chapter the occurrence, application and synthesis of different quinones are presented. 
At the end of this dissertation further oxidation and reduction reactions are summarized. 
This dissertation is presented as a cumulative collection of publications which have been 
already published or are accepted for publication in international peer-reviewed journals. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
1. Introduction – Quinone  
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Quinones are organic compounds that are considered as oxidation products of aromatic 
substances. Oxidations of arenes or phenols to quinones constitute biological 
processes,[12] which have important roles in living organism (photosynthesis, respiratory 
chain). In addition, they have a wide variety of applications in industry for example as 
catalyst of hydrogen peroxide production or pulping (vide infra).  
Typically, quinones have two carbonyl groups and two carbon-carbon double bonds in a 6-
membered ring, forming a system of conjugated double bonds (a quinoid structure or 
system) (Figure 6) causing a specific reactivity of these compounds.[1]  
quinoid 
sructure  
Figure 4: Quinoid structure. 
 
The base body of the quinones are derived from benzene, 1,2 - and 1,4-benzoquinone or 
rather called o- and p-quinone (vide supra, Scheme 5). These compounds are intensive red or 
yellow colored, pungent odorous substances resulting from oxidation of catechol and 
hydroquinone (vide supra, Scheme 5).[13] The occurrence of electron-donating substituents 
at aromatic rings increases their nucleophilicity and contributes to a large redox potential 
needed to break their aromaticity. Other quinones are 1,4-naphthoquinone and 9,10-
anthraquinone, which are the basis of many colors.  
2CrO3, H2SO4
-Cr2O4, H2O
2CrO3, H2SO4
-Cr2O4, H2O
O
O O
O
naphthalene
phenanthrene
1,4-naphthoquinone
9,10-phenanthrenequinone
 
Scheme 10: Synthesis of 1,4-naphthoquinone and 9,10-phenanthrenequinone. 
 
They can be produced by oxidation of arenes, which is the most general methodology for 
formation of quinones from naphthalene-, anthracene and phenanthrene compounds 
(Scheme 10).[1] 
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Linear condensed quinones such as 9,10-anthraquinone can be prepared by electrophilic 
acylation of arenes with phthalic anhydride (Scheme 11).[1]  
O
O
O
AlCl3 or H2SO4
O
HO2C
H2SO4
O
O  
Scheme 11: Fiedel-Crafts-Acylation of arene with phthalic anhydride. 
 
Basically all quinones have two common characteristics: First, they are almost all colored 
and secondary, they show a typical standard redox potential (Table 2).[14,15,16,17] The 
latter ability to compose a reversible oxidation-reduction cycle finds applications at electron 
carriers in energy metabolism in nature (photosynthesis or respiratory chain), but also in 
industry (photography or quinhydrone electrode).  
One advantage in the application of quinones is the significant change of standard redox 
potential by substituents (halogen, cyano, alkyl, hydroxyl groups, and so on).[18,19] The 
potential is decreased by introduction of electron-donating groups such as OH (Table 2), 
and increased by  electron-withdrawing groups such as Cl or NO2 (Table 2)).  
 
Table 2: Standard redox potential of different quinones. 
 
Quinone Standard redox potential 
1,4-benzoquinone[18] +0.715 V 
nitro-1,4-benzoquinone[14] +0.765 V 
1,2-benzoquinone[14] +0.810 V 
3-hydroxy-1,2-benzoquinone[14] +0.677 V 
1,4-naphthoquinone[17] +0.484 V 
1,2-naphthoquinone[17] +0,576 V 
1,2-naphthohydroquinone [15] +0.578 V 
9,10-anthraquinone[16] +0.154 V 
3,4-phenanthrenequinone [15] +0.623 V 
dichlorodicyanoquinone (DDQ) [19] +1.150 V 
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1.1 Occurrence 
Due to the unique characteristics of quinones, they are diverse in nature and play important 
roles in living organisms. They all have a quinoid structure, but an exchange of substituents 
or their position can change occurrence and/or application, e.g., lawsone (2-hydroxyl-1,4-
naphthoquinone) and juglone (5-hydroxyl-1,4-naphthoquinone)(Figure 5).  
O
O
OH
2-hydroxyl-1,4-naphthoquinone
lawsone
O
O
5-hydroxyl-1,4-naphthoquinone
juglone
OH
 
Figure 5: Lawsone and juglone, 1,4-naphthoquinone derivates. 
 
Lawsone, is a brown colored powder, which can be isolated from the leaves of the henna 
plant (Lawsonia inermis) as well as jewelweed (Impatients balsamica). Since ancient times it was 
used at the Indian Subcontinent for decorating and dyeing hands, soles, beard and hair and 
to impart beautiful shades of dark red color.[20] The second hydroxyl-naphthoquinone is a 
chemical released by walnut trees (Juglans nigra), which can be toxic at various levels to 
several plant species.[21] It is used as herbicide, coloring agent for foods and cosmetics and 
as a dye for cloth and inks.[ 
More than 120 naphthoquinones have been isolated from plants.[22] In nature, quinones 
are particularly common in dyes, from fungi, bacteria or flowers, in photosynthesis 
(plastoquinone Q9) and respiratory chain. In the latter one ubiquinone (Q10) plays a big 
role as an electron carrier.  
Also in insects, e.g. bombardier beetles, rather in their defensive secretions, primarily 
benzo- and toluquinone are found. Some vitamins have a quinoid structure including 
vitamin K (phylloquinone, menaquinone, menandione) (Figure 10, vide infra) and vitamin E 
(Figure 12, vide infra) (-tocopherol). Vitamin K1 is found in plant foods, for example, in 
soybeans, milk and milk products, flesh, tomatoes, rose hips, green vegetables and 
potatoes. In contrast to that, vitamin K2 is synthesized by intestinal bacteria.[23] 
Nevertheless the vitamin K3 is a synthetic vitamin. 
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1.2 Application 
Quinones are used in wide variety of applications in industries and are applied especially 
for drug construction in medicine, because a variety of quinone compounds including 
naturally occurring compounds, especially the naphthoquinone derivatives have wide 
variety of bioactivities. 
The best known natural naphthoquinones with bioactivities are vitamin K1 and K2 
(phylloquinone, menaquinone). They are known as antihemorrhage vitamins. Atovaquone 
is another important naphthoquinone derivative, which is used as a malaria drug (Figure 6) 
and has also an anti HIV activity. Other compounds with naphthoquinone structure have 
been developed as key composition of wide variety of medicine. 
O
O
HO
Cl  
Figure 6: Atovaquone. 
 
Quinones such as nanomycin, daunomycin and adriamycin, (Figure 7) are used for the 
manufacture of antibiotics. Originally, the latter two have been developed as anticancer 
drug. 
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nanomycin A daunomycin or daunorubicin adriamycin or hydroxydaunorubicin  
Figure 7: Nanomycin, daunomycin and adriamycin. 
 
Quinones also have potential for application as anti-inflammatory agent, anti-allergic agent 
and hypotension.[24] They can be used for the production of infection drugs as anti-fungal 
agents, anti-virus medicines and antibacterial agents against gram-positive bacteria, gram-
negative bacteria, and so on. In the field of animal drugs, menadione (vitamin K3, Figure 
10, vide infra) is used as a hemostatic, a feed additive. 
There are other applications mainly used for human. Quinone derivatives are used in the 
cosmetic. For example vitamin E (Figure 12, vide infra) is an antioxidant and is used for sun 
cream. Additionally, they are extensively used in the dye, chemical, tanning, and textile 
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industries, while in the pulp and paper industry quinone compounds find application as 
cooking additive.[25] Other application fields are the manufacturing industries and 
chemical laboratories associated with protein fiber, photography, hydrogen peroxide 
(anthraquinone) and gelatine making.[26] 
Another important area is the agricultural usage. Here chemicals were used or developed to 
raise the productivity of farm products by improving or controlling their physiological 
functions and protect crops by ridding of pathogenic fungi, harmful insect, weeds and rats. 
There are some types such as insecticides (pristimerin), fungicides (delan), herbicides 
(mogeton), plant growth regulators, anti-fouling agent, bird repellents (Figure 8).[27] 
S
S
N
N
O
O
delan
O
O
Cl
NH2
mogeton
O
HO
H
CO2Me
pristimerin
Figure 8: Figures of pristimerin, delan and mogeton. 
 
In addition quinones are good oxidants and can used for redox reaction for example in the 
electrochemistry as electrode.  
 
In the next sections detailed applications of selected quinones are shown and explained in 
detail.  
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1.3 Hydroquinone 
Hydroquinone has a variety of applications. For example, it can be used in medical 
applications, as monomer inhibitors, for making dyes and pigments, as agricultural 
chemicals, and so on. Some applications and the important roles of the hydroquinone are 
discussed here more in detail. 
 
1.3.1 Application 
1.3.1.1 Photography  
Hydroquinone is a dihydroxybenzene and can easily be oxidized to quinone. This reducing 
effect is exploited in the photography. During the expose the small silver halide grains 
which are suspended in the photosensitive layer accumulate development nucleus. The 
developer (hydroquinone) attacks at the nucleus and reduces the silver ions to black, silver 
metallic. During the fixation the unexposed silver halide grains are usually extracted with 
sodium thiosulfate, to make the left layer light-resistant (Scheme 12). 
OH
OH
O
O
+ 2OH- H2O + 2e-
2Ag+ + 2e- 2Ag
Oxidation
Reduction
+
 
Scheme 12: Reactions during the photography. 
 
1.3.1.2 Charge transfer complex  
The reduction of 1,4-benzoquinone (yellow) to hydroquinone (colorless) develops a 
reactive intermediate the so called quinhydrone (dark green/brown). It can also be 
obtained by mixing equivalent quantities of p-benzoquinone and hydroquinone. In the 
presence of light, an electron is transferred from hydroquinone (donor) to p-benzoquinone 
(acceptor) giving the quinhydrone the very characteristic purple color. 1:1-adducts with this 
property are called "charge transfer complexes" (CT-complex) or “donor-acceptor-
complex” (Scheme 13).[1] 
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Scheme 13: Charge transfer complex.
 
The +M-effect of the two OH groups of the hydroquinone increased the electron density 
in the aromatic six-membered ring, so it can act as electron rich donor. The benzoquinone 
is the acceptor, his six-membered ring show an electron deficiency due to the -I-effect of 
the two oxygen substituents.  
O
O
O
O
O
O
O
O
+e- +e-
p-benzoquinone semiquinone-radical-anion hydroquinone-dianion
+ 2H
 
Scheme 14: Semiquinone-radical-anion. 
 
The interaction of -electrons leads to a facilitated excitability by electromagnetic radiation. 
For this reason all CT-complexes show demonstrative staining. Thereby, the electron 
exchange takes place in two steps over the detectable resonance stabilized semiquinone 
radical anion (Scheme 14). 
 
1.3.1.3 Electrochemistry: quinhydrone electrode 
The redox system hydroquinone / benzoquinone in the molar ratio 1:1 is used in the pH-
measurement as the so called quinhydrone electrode. Thus, pH measurements in acidic and 
neutral solutions can be realized. It consists of a platinum plate (inert metal electrode), 
which dips into the saturated quinhydrone (quinone:hydroquinone, 1:1) analysis 
solution.[28] Here, the electrode charged to a particular potential, which is measured by a 
reference electrode. The electrode half-reaction is shown in Formula 1 (2). The electrode-
potential E of this organic half cell can described in accordance with the equation: 
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Formula 1: Electrode potential of the quinhydrone electrode. 
 
The equation allows a fast and easy determination of the hydrogen ion concentration of 
any solution. However, the disadvantage of the electrode is the limitation to an acidic or 
neutral medium. In an alkaline solution the hydroquinone behaves like a very weak acid 
and absorbs hydroxyl ion, so a too high hydrogen ion concentration is determined. 
Additionally, the hydroquinone will be oxidized quickly to organic acids.  
 
1.3.1.4 Bombardier beetle  
In nature hydroquinone plays an important role in the animal world of insects. The so 
called bombardier beetle (Carabidae, Brachinini) uses hydroquinone in the defence 
mechanism of arthropods. These insects respond to disturbance by ejecting a quinoid 
secretion from a pair of glands that open at the tip of the abdomen.[29] They aim their 
discharge by revolving the abdominal tip and direct their spray with accuracy toward any 
region of the body subjected to assault.[30] The discharges are accurately aimed [30,31] and 
they occur with audible detonations, hence the name ‘bombardiers’. The active component 
of the secretion is 1,4-benzoquinone[29], a compound known to be potently irritating[32]. 
The defensive reaction takes place in the middle of the beetle. The beetle has two glands 
where the chemicals ordinarily stored separately. Each gland consists of two confluent 
compartments. In the major compartment (the reservoir or storage chamber) are hydrogen 
peroxide and hydroquinone and the other (the reaction chamber) contains a mixture of 
enzymes (catalase, peroxidase).[33]In the moment of defense, several reactions take place. 
The quinone is generated explosively at the moment of ejection by the mixing of two sets 
of chemicals[34] (Scheme 15).[35] 
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Hydroquinone (aq) Quinone (aq) + H2 (g) H=+42.4 Kcal/mol
H2O2 (aq) H2O (l) + 1/2 O2 (g) H=-22.6 Kcal/mol
H2 (g) + 1/2 O2 (g) H2O (l) H=-68.3 Kcal/mol
peroxidase
catalase
Hydroquinone (aq) Quinone (aq) H=-48.5 Kcal/mol  
Scheme 15: Defensive reaction of the bombardier beetle. 
 
When combined, the reactants undergo a violent exothermic chemical reaction, (Scheme 
15) and their temperature raising near to the boiling point of water (100 °C).[36]  
To activate the spray, the beetle squeezes fluid from the reservoir into the reaction 
chamber. This results in the instantaneous liberation of oxygen from hydrogen peroxide, 
and the oxidation of the hydroquinones to quinones by the freed oxygen. The 
corresponding pressure buildup forces the entrance valves from the reactant storage 
chambers to close, thus protecting the beetle's internal organs. The boiling, foul-smelling 
liquid partially becomes a gas and is expelled through an outlet valve into the atmosphere 
with a loud popping sound.[29,35,37] An audible detonation accompanies the discharge. 
The spray is an effective deterrent to predators.[38] The flow of reactants into the reaction 
chamber and subsequent ejection to the atmosphere occurs cyclically at a rate of about 500 
times per second and with the total pulsation period lasting for only a fraction of a second. 
 
1.3.2 State-of-the-art Synthesis 
All current routes for the synthesis of hydroquinone utilize benzene as the starting material 
(Scheme 16). The manufacture of hydroquinone is now dominated by oxidation of phenol 
and 1,4-diisopropylbenzene.[39] The first route begins with Friedel-Crafts alkylation of 
petroleum-derived benzene to afford cumene. Subsequent Hock-type, air oxidation of the 
cumene leads to formation of acetone and phenol. Additionally this is currently the 
predominant method used in the production of phenol, which amounts to 5x109 kg 
annually.[40] The phenol is then oxidized using 70% hydrogen peroxide either in the 
presence of transition metal catalysts or in formic acid solution where performic acid is the 
actual oxidant. The generated catechol and hydroquinone mixture is separated into its pure 
components by distillations.  
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Scheme 16: Synthesis of hydroquinone. 
 
The second synthesis way, which is also manufactured, is the reaction with propene and 
benzene to 1,4-diisopropylbenzene, which reacts afterwards to the hydroquinone.[41] 
Nevertheless there are more than this two synthetic routes.  
Benzene reacts to nitrobenzene by using HNO3 and H2SO4 and after that to the 
corresponding aniline. Next, benzoquinone is synthesized by a route employing 
stoichiometric amounts of MnO2 to oxidize aniline, followed by iron catalyzed reduction to 
the corresponding hydroquinone.[42] While benzene is a volatile carcinogen derived from 
non-renewable fossil fuel feedstocks, an alternative way to hydroquinone has been 
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elaborated (Scheme 16).[43] Glucose is nonvolatile, nontoxic, and derived from renewable 
plant polysacharrides and plays an important role for these benzene free routes. From 
Glucose Escheria coli produce shikimic acid (SA), quinic acid (QA) and 3-dehydroshikimic 
acid (DHS).[44] Shikimic acid as well as quinic acid are known for the hydroquinone 
synthesis (Scheme 16). In 1995 the manufacture of hydroquinone and catechol has been 
elaborated that utilize D-glucose as the starting material and biocatalysts, a genetically 
modified microbe, Escheria coli.[43c)] Here the shikimic acid was the precursor for the 
quinones. Furthermore the synthesis of hydroquinone by an alternative benzene free route 
was published in 1838. Woskresensky synthesized the quinone from quinic acid.[45] In 
1992 Drahts et al. reported about the production of quinic acid from glucose with Escheria 
coli.[46] They also published the oxidation of quinic acid with stoichiometric amounts of 
MnO2 to benzo- and hydroquinone in low to modest yield. Next Ran and co-workers 
developed a new catalytic route from quinic acid to hydroquinone.[47] They used 
stoichiometric amounts of NaOCl, (NH4)2Ce(SO4)3, V2O5 or catalytic quantities of 
Ag3PO4/K2S2O8  to afforded 74% to 91% yield. One year later Hansen and Frost 
published a synthesis of 2-deoxy-scyllo-inosose from glucose which reacts to 
hydroxyhydroquinone (Scheme 17).[48]  
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Scheme 17: Synthesis of hydroquinone, a benzene free route. 
 
The latter is the starting material for the hydroquinone synthesis catalyzed by Rh/Al2O3, 
Rh/C, Pt/C, or Pd/C. The Rh on Al2O3 catalyst showed the best results (53% yield), 
whereas the Pd on carbon showed less activity (18% yield).   
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1.4 Ubiquinone 
Some of the most well known quinones are called ubiquinones, also known as coenzymes 
Q or vitamin Q. Their structurally similarity is based on a 2,3-dimethyl-1,4-benzoquinone 
molecule with a side chain of isoprenyl units (Figure 9). They designated to the number of 
isoprenyl units of their side chain as Q1, Q2, and so on. In Escherichia coli Q1 to Q8 have 
been found, in fish Q9 and in rat Q11 and Q12. In most mammals including humans Q10 
is predominant and, therefore, it has attracted most interest. All ubiquinones are naturally 
occurring, fat-soluble quinones that are localized in hydrophobic portions of cellular 
membranes. They serve as electron transferring compounds in the light dependent reaction 
of the photosynthesis and in respiration. 
O
O
O
O
H
n
n=9:    Ubiquinone
n=10:  Plasroquinone  
Figure 9: Ubiquinones Q9 and Q10. 
 
1.4.1 Application 
1.4.1.1 Photosynthesis 
Photosynthesis was one of the driving evolution factors in the early earth’s history, because 
it is responsible for the production of oxygen, which is required by aerobic organisms 
(Scheme 18). Additionally, it is the momentum behind most of the life on our planet, 
which occurs in plants, algae and some types of bacteria. In oxygenic photosynthesis, 
electron transport occurs in the thylakoid membrane and requires coordinated interactions 
between a large number of electron-carrier compounds and enzymatic proteins that 
facilitate the transfer of electrons (reducing power) from dissociated H2O molecules to 
NADP.  
light reaction:  
  222 61812181212 OATPNADPHPADPNADPOH hv   
dark reaction: 
 PADPNADPOHOHCATPNADPHCO  1812618126 2612622  
total: 
OHOOHChvOHCO 22612622 66126   
Scheme 18: Reactions in the photosynthesis. 
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The electron-transport components are highly organized in the thylakoid membrane and 
facilitate the transfer of electrons laterally in the plane of the membrane from the grana 
regions (appressed) to the stroma-exposed (unappressed) regions. The redox map of 
photosynthesis of these organism can be described in terms of the well-known Z-scheme 
proposed by Hill and Bendall.[49] A photochemical reaction occurs at the photosynthetic 
reaction centre, which can be divided into 2 sections, photosynthesis I and II. The quinone 
plays an important role in the photosynthesis II. It is used as an electron transfer between 
pheophytin and plastocyanin over cytochrome b/f.  
In photosystem II (PSII), light activates electron transfer from the primary donor 
chlorophyll (P680) D to the primary quinone acceptor QA and then to the secondary 
quinone acceptor QB, in the reaction centre. The tightly bounded QA is a one-electron 
carrier, whereas the loosely bounded QB can accept two electrons. [50,51] Scheme 19 
shows the mechanism of the quinone in the photosynthesis.  
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Scheme 19: Mechanism of the quinone in the  photosynthesis. 
 
In the first step 1 light activates the DQAQB complex and a charge couple D+QA-QB is 
generated. After that the chlorophyll D+ is reduced by a cytochrome cyt c2+ and the cyt c2+ 
was oxidized to cyt c3+ (step 2). From the QA- the electron is transferred to the secondary 
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quinone electron acceptor, QB (step 3). The first two steps repeats (step 4) and results in a 
two charged quinone. The first proton H+(1) is taken up from solution and transferred to 
the reduced semiquinone QB- before the second electron transfer (step 5) to generate an 
uncharged quinone QA (DQAQBH-) [52]. The second proton H+ (2) is transferred internally 
(step 6) and a hydroquinone QBH2 (DQAQBH2) is generated. The QBH2 diffuses out of the 
reaction centre into an also membrane bound cytochrome bc1 complex and is reoxidized to 
the quinone state. In steps 8 and 10 the protons were delivering. Due to the spatial 
arrangement of the protein complexes the protons are taken up in steps 5, 6 in the interior 
of the cell and expelled in steps 8, 10 to the periplasmic space. This process generates an 
electrochemical gradient across the cytoplasm membrane. The quinone cycle is closed by 
transfer of the quinone back to the cycle (step 11). 
 
1.4.1.2 Respiration 
Ubiquinone serves in the respiration as an electron transferring compound. The quinone is 
important for the complex III in the respiration chain. This complex is a membrane-bound 
protein complex that conduces as electron acceptor from the hydroquinone (QH2) and 
electron donator to cytochrome c (cyt c). It consists of three catalytic subunits (with 
cofactors): cytochrome b (two hemes), cytochrome c(1) (heme), and the Rieske iron-sulfur 
protein ([2Fe-2S] cluster).  
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Scheme 20: Mechanism of the quinone in the respiration chain. 
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The electron transfer mechanism is known as the bifurcated Q-cycle[53] and is shown in 
the Scheme 20. At first the ubiquinone Q reduced to the ubihydroquinone QH2 by the 
complexes I and II. Now it is possible for the QH2 to diffuse in the membrane and to 
deliver the absorbed 2 electrons. The hydroquinone tethers on the Q0site in the complex 
III.  
The Rieske protein first accepts an electron from a QH2 molecule, and then donates the 
electron to cyt c.[52d),e)] The second electron is recycled to reduce the Q to 
ubisemiquinone QH in the cytosolic side (Qi). In the Q0site the QH2 donate two hydrogens 
into the inner-membrane-space and reduce to the oxidized Q, which diffuse back to the 
ubiquinone pool. These reactions steps repeat again and again one cyt c and one 
semiquinone were produced. The semiquinone in the Qisite, absorb two hydrogens from 
the matrix and reduce to the QH2. The rate-limiting step occurs in the first electron 
transfer to the Rieske protein.[52d),e),54] The net reaction is to oxidize the hydroquinone 
to quinone, reduce two cytochromes c, release four protons into the inner-membrane-
space, and transfer two protons across the membrane, against the proton gradient. 
1.4.2 State-of-the-art Synthesis 
Fortunately quantities of Q10 are available by well established fermentation [55] and 
extraction processes. Apparently more cost-efficient route in comparison to total synthesis 
is not available. Thus, the costs of these materials for research purposes are astonishingly 
high: e.g., Q9 is 119.00 €/g, and CoQ10 is 423.00 €/g [56].  
First results of isolation of Q10 were published in 1957. Crane and co-workers isolated 
Q10 from mitochondria of beef heart.[57] Several approaches to synthesize ubiquinones 
have been developed the past 3-4 decades, attesting to the importance of these 
compounds. All side chains have to be confirmed to trans-configuration.[58] The first 
industrial approach by Hideaki Fukawa at Nisshin in 1974 [59] based on direct 
polyprenylation of hydroquinone monoacetate by Friedel- 
Crafts-type coupling is still exclusive for the partial synthesis of this vitamin. However, this 
process is, unfortunately, attended with some unwanted side reactions, especially partial 
cyclization to a chromanol type compound and (E)/(Z) isomerization during coupling. 
Moreover, the coupling yield is very low (20%). 
As early as 1959 Isler et al. reported the first synthesis of ubiquinones Q9 and Q10 in 
about 20% and 71% yield by using 5-methyl-2,3-dimethoxy-hydroquinone and an 
isoprenoid alcohol (solanesol or decaprenol) in diethyl ether in the presence of ZnCl2 as 
catalyst (Scheme 21). [60]  
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Scheme 21: Synthesis of ubiquinone. 
 
This condensation step was advanced in the following years. In 1970 Fukawa et al. 
patented an improved method for ubiquinone coenzyme Q9-Q12 synthesis using ZnCl2, 
AlCl3 and BF3 ether complex with 5-methyl-2,3-dimethoxy-hydroquinone or its 4-acyl 
derivative and the appending isoprenyl alcohols.[61] The application of another catalyst 
was reported in 1976. Kijima and co-workers used silica-alumina as catalyst to get after 
purification 25.8% yield of Q9 and 49.2% yield of Q10.[62] One year later they described 
the reaction of 2-methyl-4,5,6-trimethoxyphenol with boronic acid to obtain the 
corresponding borate which then reacts with a prenol or isoprenol hydrolyses and finally is 
oxidized to Q10.[63] Later Eto et al. used BF3 OEt2 as catalyst for the condensation and 
increased the yield to 51% (46% isolated yield).[64] The stereoselectivity was also increased 
to 92:2 (E/Z), respectively after purification >99:1. They also changed the compounds and 
used isodecaprenol which reacts with the hydroquinone in hexane/nitromethane (1:2, v/v) 
mixture as solvent to Q10 (Scheme 22).  
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Scheme 22: Reaction with isodecaprenol to Q10.  
 
Nevertheless, these processes are not useful for commercialisation due to large amounts of 
catalysts required for the condensation and/or their corrosive behaviour. Recently, Aquino 
et al. patented new results with this condensation method.[65] They synthesized Q9 and 
Q10 by using 2,3-dimethoxy-5-methylhydroquinone, prenol or isoprenol in the presence of 
a Brønsted-acid, a Lewis-acid, heteropolyacid, an NH- or a CH-acidic compound. The 
ubiquinone is obtained in good yield (36% to 50%) and E/Z-ratio (92:8 to 94:6) depends 
on the catalyst. 
Also other methods for the synthesis of the coenzymes were developed. For example the 
synthesis of the quinone by using a -allyl nickel bromide complex and protected quinones 
published by Sato et al. [66] They start manufacturing the coenzyme Q1 and later they 
adopted this procedure for the Q9 and Q10.[67] At first they synthesized the decaprenyl 
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nickel bromide with 9 or 10 units. These complexes react then with a protected bromo-
quinone in phosphoramide at 70 or 75 °C to afford the protected Q9 or Q10 in 45% or 
40% yield. This compound was then converted by removal of the acetate groups with 
LiAlH4 and by subsequent oxidation by aq. FeCl3 to the coenzymes Q9 or Q10 in a yield of 
71% or 69% (Scheme 23).  
Br +
n
H2
C
HC
C
H2
Ni
Br
Ni
Br
C
H
CH
H2
C C
HC
C
H2
Ni
Br
Ni
Br
C
H
CH
C
CH2 H
n=8 or 9
CH2 H
n
MeO
MeO
OAc
Br
OAc
MeO
MeO
OAc
OAc
n
n=9 or 10
Q9 or Q10LiAlH4
FeCl3
n=9 or 10
decaprenyl nickel bromideally nickel bromide complex
 
Scheme 23: Synthesis of Q9 or Q10 by -ally nickel bromide complex. 
 
The overall yield of the process is only 28%. Further drawbacks like the presence of only cis 
isomer and the high flammability of the formed nickel carbonyl make this process not 
suitable for industry. Another method is the reaction with unprotected quinone and allyl-
stannyl compounds published in 1979 and 1980 (Scheme 24).[68] 
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Scheme 24: Reaction with allyl-stannyl. 
 
Naruta and co workers synthesized the stannyl reagent, which reacts with quinone and 
BF3.OEt2 in a solvent mixture (CH2Cl2/hexane or CH2Cl2/isooctane) at -50 to -55 °C or -
45 to -50 °C to the desired products Q9 or Q10 in both 51% yield (100% or 86% trans).  
Another method of producing ubiquinones is the carboalumination of unactivated alkynes 
(Scheme 25). This procedure has been developed by Negishi [69] and later used by 
Lipshutz [70]. Starting from 3-butyn-1-ol the compound (E)-6,10-dimethyl-1-trimethylsilyl-
5,9-undecadien-1-yne was synthesized followed by nine steps giving Q10 in 26% overall 
yield. No stereoisomeric separation was attempted in the synthesis of 98% (all-E). 
1.4 UBIQUINONE 
- 27 - 
I
I
8 steps
MeO
MeO
O
O
10
26% overall
>98% all-E
TMS
KOH-MeOH
Me3Al, Cl2ZrCp2, ClCH2CH2Cl
MeO
MeO
O
O
Cl
Scheme 25: 9 steps synthesis of Q10. 
 
In 2005 Yu et al. synthesised Q10 in ten steps reaction (Scheme 26).[71] They used 
commercially available 2,3-dimethoxy-5-methylbenzoquinone which reacts after 6 steps to 
1-[(2E)-4-bromobut-2-en-1-yl]-3,4-dimethoxy-2,5-bis(methoxymethoxy)-6-methylbenzene. 
This compound reacts in 9 steps and deprotection to the Q10 in approximately 28% yield 
overall. 
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Scheme 26: 10 steps reaction to Q10. 
 
In 1981 Fujita and co-workers patented the reaction of ubiquinone with Grignard 
reagents.[72] The reactive sulfur compound is readily prepared by reaction of a Grignard 
reagent with a halo-sulfone and a copper compound, as follows: 
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copper 
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Scheme 27: Synthesis of ubiquinone using Grignard reaction. 
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According to this procedure Q10 is obtained in 5% to 67% yield. Nearly two decades later 
a new synthesis using Grignard reagent was patented. [73] Upare et al. got Q9 and Q10 in 
50-56% yield and purity of 98%.  
 
 
1.5. Anthraquinone 
In nature anthraquinones occur in plants like fungi or in insects. It is an important 
substrate for the production of laxative, which is used in the medicine, production of dye 
stuff and paper fabrication. Nevertheless, the most important application is in the H2O2 
manufacturing.  
 
1.5.1 Application 
1.5.1.1 Hydrogen peroxide manufacturing 
Hydrogen peroxide (H2O2) is a colorless liquid, miscible with water in all proportions and 
weakly acidic. The manufacturing process involves the reaction of H2 with atmospheric O2 
to give H2O2. Hydrogen peroxide is manufactured using the anthraquinone process as a H2 
carrier.  
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Scheme 28: The Anthraquinone Process for H2O2 Manufacture 
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This process is a cyclic operation where an alkyl anthraquinone is reused. The synthesis 
loop consists of sequential hydrogenation, filtration, oxidation, hydrogen peroxide 
extraction and treatment of the working solution.[74] Scheme 28 shows a simplified flow 
diagram of the process steps. A number of ancillary processes are also involved. 
The alkyl anthraquinone is important for the hydrogenation and oxidation step. In the step 
of the hydrogenation an alkyl anthraquinone AQ; usually 2-ethylanthraquinone, which is 
dissolved in appropriate solvent or mixture of solvents, one nonpolar and the other polar, 
is catalytically hydrogenated. The main reaction, which is known as the Riedl-Pfleiderer 
process[75] (Scheme 29), currently accounts for the largest part of hydrogen peroxide 
production (Scheme 30).  
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Scheme 29: Riedl-Pfleiderer process. 
 
In the reaction solution AQ is hydrogenated at 4 bar using a simple palladium-on alumina 
catalyst.[72] Temperature is controlled to around 40-50 °C.  
O
O
R
OH
OH
R
H2
O
O
R
O
O
R
2 H2
2-alkylanthraquinone AQ 2-alkylanthrahydroquinone AHQ
5,6,7,8-tetrahydroalkylanthraquinone THAQAQ
5,6,7,8-tetrahydroalkylanthrahydroquinone THAHQ
O
O
R
OH
OH
R
H2
THAQ
[Pd]
[Pd]
[Pd]
Scheme 30: Hydrogenation steps of anthraquinone derivate. 
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During hydrogenation AQ is converted to the alkyl anthrahydroquinone AHQ (Scheme 
30). However, a side reaction is the hydrogenation of the unsubstituted aromatic ring to 
yield 5,6,7,8-tetrahydroalkyl-anthrahydroquinone THAHQ. The formation of this product 
is favoured because of the easier hydrogenation. 
This by-product must be removed and treated periodically. The organic solvent employed 
is typically a mixture of an aromatic (a good solvent for the AQ) and a long-chain alcohol 
(a good solvent for the AHQ). After hydrogenation the solution AHQ is separated from 
the hydrogenation catalyst by the so called filtration process. The third step of the process 
involves the oxidation of the AHQ, regenerating the AQ, with oxygen (as air or oxygen). 
This uncatalyzed step produce simultaneously equimolecular amounts of hydrogen 
peroxide (Scheme 31).[76,77]  
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Scheme 31: Uncatalyzed oxidation of AHQ with O2 to AQ and H2O2. 
 
The solution is oxidized by blowing air through it at 30-60 °C and near atmospheric 
pressure. This reaction occurs by means of a well-documented free-radical chain 
mechanism (Scheme 32).[78]  
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Scheme 32: Free-radical chain mechanism. 
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At first, an initiator (In), which can be an impurity in the hydrogen peroxide, can abstract a 
tertiary hydrogen atom of AHQ. After that the radical reacts with oxygen to form a 
hydroperoxyl radical and this reacts with a second AHQ molecule to give an instable 
alcohol hydroperoxide and an AHQ radical. In the third step the former product 
decomposes to a ketone and hydrogen peroxide, and the latter starts another propagation 
cycle. No catalyst is used and hence this step is often referred to as auto-oxidation.  
After the oxidation step the hydrogen peroxide is stripped from the organic working 
solution by demineralised water in a counter current column to produce a solution that 
contains usually 30% by weight H2O2. Then, the aqueous H2O2 is distilled to remove 
impurities and increase the concentration to up to 70%, and the solvent/anthraquinone 
mixture is recycled.  
There are advantages and disadvantages of the anthraquinone process. An advantage is the 
high yield of hydrogen peroxide per cycle. Nevertheless, there are two major drawbacks. 
On the one hand side reactions require regeneration of the solution and the hydrogenation 
catalyst. On the other hand a separation step to remove organic impurities from the 
hydrogen peroxide product is needed.  
 
1.5.2 State-of-the-art Synthesis 
The synthesis of anthraquinone and its derivates are well known. One of these methods is 
the oxidation of anthracene with various oxidizing agents such as molecular oxygen,[79] 
hydrogen peroxide,[80] ozone,[81] nitric acid,[82] chlorine,[83] and so on (Scheme 33). 
O
O
[cat]
oxidation
anthracene anthraquinone
Scheme 33: Oxidation of Phenanthrene to the corresponding quinone. 
 
The acylation of benzene with phthalic acid in the presence of aluminium chloride to 
obtain o-benzoyl benzoic acid is also published.[84] In the second step the acid is cyclized 
to anthraquinone in a medium such as concentrated sulphuric acid, polyphosphoric acid or 
hydrofluoric acid. 
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Scheme 34: Synthesis of the quinone from phthalic acid and benzene. 
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Furthermore, the quinone can be synthesised by a Diels-Alder reaction. In this case 1,4-
naphthoquinone reacts with 1,3-butadien in an autoclave, followed by oxidation in air to 
the corresponding anthraquinone (Scheme 35).[85] 
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Scheme 35: Diels-Alder reaction.  
 
In nature anthraquinone derivatives can be isolated from eukaryotic organism (fungi, 
higher plants and insects) and/or prokaryotes (bacterial organism).[86] In the last years the 
biosynthesis of these anthraquinone compounds were reviewed. Thus, it is known that 
anthraquinones like chrysophanol (Scheme 37) are biosynthesized via the polyketide 
pathways (Scheme 36).  
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Scheme 36: Polyketide pathways. 
 
Until now three different pathways lead to chrysophanol in nature: one eukaryotic 
polyketide folding mode F (as initially established for fungi) and two different prokaryotic 
polyketide folding modes S (as expected for Streptomyces) and S’.[87] However, they always 
start from eight C2 units derivated from acetate and malonate (Scheme 35). 
Biosynthetically, polyketides are usually built up by successive Claisen condensation of an 
acyl-CoA starter unit with 7 molecules of malonyl-CoA catalyzed by polyketide synthases 
(PKS)[88] to provide an octa--keto-acyl chain  (Scheme 36). Then the molecule gets 
diversely folded and reacts further in a divergent way, via three different series of 
intermediates and still, all of them finally provide the target molecule chrysophanol.  
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Scheme 37: Three different routs to chrysophanol in nature. 
 
 
1.6 Phenanthrenequinone 
Both phenanthrene and anthracene have preferential reaction centres at the meso-positions 
C-9 and C-10 thereby the two benzene-ring systems were sustained. Oxidation provides 
9,10-quinone (Scheme 38).  
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Scheme 38: Reactions of phenanthrene and anthracene.  
 
In comparison with similar reactions of the naphthalene they need mild reaction 
conditions. The most common photooxidation and biotransformation product of 
phenanthrene is phenanthrenequinone[89]. The quinone is a compound of substantial 
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interest, because its toxicity to aquatic organisms can be much higher than in its parent 
chemical. Phenanthrenequinone act in the redox cycle in bacterial cells and transfer 
electrons to O2.[90]  
 
1.6.1 Application 
1.6.1.1 Redox cycle 
By virtue of their quinones, these agents can undergo a biochemical reduction by one or 
two electrons that are catalyzed by different enzymes such as cytochrome P450, 
cytochrome P450 reductase or flavoenzymes in the organism using NADPH as an electron 
donor.  
This bioreductive process leads to the semiquinone and hydroquinone of anticancer 
drug.[91] The process of reductive activation is the first step in the process of redox cycle. 
The consequence of these enzymatic reductions is that the semiquinone (unstable) yields its 
extra electron to oxygen with the formation of superoxide radical anion (O.2-) and the 
original quinone (reactive oxygen species). This reduction by a reductase followed by 
oxidation (molecular oxygen) is known as redox-cycle and continues until the system 
becomes anaerobic (Scheme 39). 
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Scheme 39: 1- and 2-electron reduction.  
 
In the case of a 2-electron reduction, which is more complicated, the hydroquinone could 
become stable (Scheme 39). The 2-electron reduction leads to the formation of 
hydroquinone, which has a lower reactivity than semiquinone and as such, excreted by the 
organism in a detoxification pathway. It may also be due to autoxidation of hydroquinones 
to form reactive oxygen species (ROS). 
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In both pathways O.2- were obtained. The formation of O.2- is the beginning of a cascade 
that generates H2O2 and it also changed into the H2O by catalase, generally referred to as 
ROS.[92] Chemicals are metabolized in the body to produce many kinds of ROS. The ROS 
is changed into •OH, through the Haber-Weiss reaction and the Fenton reaction processes. 
The •OH radical makes adducts with DNA to induce mutation.[93] It is known that all 
quinone-containing antitumor agents undergo redox cycling at different rates. The 
consequences of redox cycling may change with cell line, cellular pH, oxygen 
concentration, and with the type of tumor. [94] 
 
1.6.2 State-of-the-art Synthesis 
There are a number of synthetic routes available but the most used procedure involves the 
oxidation of phenanthrene. The catalytic oxidation of phenanthrene is one of the 
possibilities to obtain the corresponding quinone in high yields (vide supra).[95] Thereby a 
variety of catalyst systems are known. Recently our group published ruthenium catalyst 
oxidation of phenanthrene in 34% to 54% yields.[80] 
However it is also feasible to achieve the 9,10-phenanthrenequinone and derivatives by 
photocatalytic reactions. Classically, this is done by oxidative photocyclization of stilbene 
followed by oxidation of the resulting phenanthrene [96] to 9,10-phenanthrenequinone 
(Scheme 40). 
hv
oxidant oxidant
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trans-stilbene phenanthrene 9,10-phenanthrenequinone  
Scheme 40: Oxidative photocycization of stilbene to 9,10-phenanthrenequinone. 
 
This route gives often low yield in the cyclization step due to competing cis-trans 
isomerization. It is also difficult to oxidize phenanthrene in high yields. In 1988 de Vries et 
al. found an alternative synthesis to resolve these problems.[97] They developed a route 
which converts benzoin into 9,10-phenanthrenequinone in 84% yield. For this two step-
reaction they first used phenylboronic acid and benzoin which gave the 2,4,5-triphenyl-1,3-
dioxoborole (Scheme 41). At this point the cis-trans isomerization is bypassed. However the 
next reaction step is the photocyclization of the dioxoborole in benzene with diphenyl 
diselenide as mild oxidant to produce a crystalline compound which react after hydrolysis 
to the 9,10-phenanthrenequinone. 
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Scheme 41: Reaction of benzoin to 9,10-phenanthrenequinone. 
 
Togashi et al. used this method and tried to synthesised 9,10-phenanthrenequinone 
derivatives with electron donating (methoxy and methyl) and electron withdrawing (chloro) 
groups on the 3 and 6 position of the quinone.[98] The substituents used in this synthesis 
did not alter the rate or yield of cyclization, or the ease of hydrolysis. Ten years later Kou 
and co workers were interested in the influence of transition metal ions on the 
phenanthrene under visible light irradiation from 420 to 520 nm.[99] They applied 
transition metal salts (FeCl3, CuCl2, MnCl2, Cr(NO3)3, NiCl2, ZnCl2, CoCl2) by using a glass 
reactor. Only FeCl3 showed some reactivity and 11 products were identified in the Fe3+-
acetone-water system.[100] The quinone and 2,2´-biphenyl-dicarboxaldehyde are the main 
products (Scheme 42) and the yield was 40.3% and 35.6%, respectively.  
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Scheme 42: Influence of trans metal ions to obtain 9,10-phenanthrenequinone. 
 
Furthermore heterogeneous photocatalytic reactions are well known, too. In 2003 Lin et al. 
used a titania thin film of titania annular photocatalytic reactor for the degradation of 
phenanthrene in dilute water streams.[101] They postulated a mechanism of the conversion 
of phenanthrene to the corresponding quinone (Scheme 43). Whereas the e/h+ couple 
generated by UV (<410 nm) illumination of titania will generate highly oxidizing species. 
However hydroxyl (•OH) and superoxide (O2•) radicals are the primary oxidizing species 
in heterogeneous photocatalytic processes. Scheme 43 show the postulated mechanism 
where the resulting hydroxyl radical attack on the 9-position of the phenanthrene and
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subsequent reaction with oxygen and superoxide radical will lead to the formation of  the 
corresponding quinone. 
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Scheme 43: Postulated mechanism of the synthesis from phenanthrene to the quinone.
 
With this reaction condition seven intermediates were identified. Photocatalytic reaction 
using TiO2 powder, acetonitrile and water (1:1) as eluent at r.t. were published 2006 by 
Higashida et al..[102] Nevertheless phenanthrene was converted to 9,10-
phenanthrenequinone which react then to cumarine. Furthermore functionalized TiO2 
photocatalyzed reaction is known. Recently Liu et al. published a thio-functionalized TiO2 
photocatalytic degradation of phenanthrene.[103] They succeeded the formation of 9,10-
phenanthrene and other degradation products in heterogeneous photocatalytic process. 
 
 
1.7 Naphthoquinone 
Naphthoquinone forms the central chemical structure of several natural compounds, for 
example the series of Vitamin K are naturally occurring 1,4-naphthoquinone derivatives 
(vide infra). Furthermore juglone, lawsone, plumbagin and atovaquone are well known 1,4-
napthoquinone derivates (vide supra). However the reactions of 1,4-naphthoquinone are 
versatile. Major reactions are nucleophilic addition, radical addition, acylation, reaction of 
quinone carbonyl, photo-chemical reaction, substitutions to aromatic ring and Diels-Alder 
reaction. After these reactions new 1,4-naphthoquinone derivates were developed, for 
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example anthraquinone. 1,4-Naphthoquinone and diene react to anthraquinone via Diels-
Alder reaction. That’s why naphthoquinone is an intermediate for the pulp and dye 
manufacture. Among them, 1,4-Naphthoquinone is industrially used as a raw material for 
pharmaceuticals, agrochemicals and other functional chemicals.  
 
1.7.1 State-of-the-art Synthesis 
The use of quinones as dienophiles has allowed the synthesis of some important natural 
products. This procedure was published in 1989.[104] Carreño and co-workers developed a 
general method to obtain chiral 2-sulfinylquinones in high chemical and optical yield. After 
this synthesis the new compound react with acyclic dienes to naphthoquinone, resulting 
from intermediate by pyrolysis of the sulfonyl group and further aromatization (Scheme 
44). The isolation of the product is unsuccessful. 
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Scheme 44: Reaction of a chiral quinone to the 1,4-naphthoquinone. 
 
Further investigations on Diels-Alder reactions with quinones were published by Itami et 
al..[105] They developed a Diels-Alder reaction with 2-PyMe2Si-1,3-diene with p-
benzoquinone in water (containing 1 eq. of HCl) with simultaneous desilylation and 
oxidation to afford naphthoquinone quantitatively (Scheme 45). 
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Scheme 45: Diels-Alder reaction with 2-PyMe2Si-1,3-diene. 
 
In the literature the synthesis of naphthoquinones via Diels-Alder by using an enzymes is 
also known.[106] Laccases are copper-containing glycoprotein oxidoreductase enzymes 
found in plants and fungi.[107] Witayakran et al. reported the use of laccase for the 
synthesis of substituted naphthoquinones. The reaction started by using catechol or 
hydroquinone with the enzyme which reacts to the corresponding quinone. Next the 
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compound reacts with a diene to the 1,2- or 1,4-naphthoquinone and its derivates. This 
reaction system can yield naphthoquinones up to 80% depending on the exact structure of 
the starting hydroquinone and diene (Scheme 46).  
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Scheme 46: Laccase catalyzed reaction to 1,2- or 1,4-naphthoquinone. 
 
However for the synthesis of naphthoquinone quite more reactions are known. First it is 
possible to obtain naphthoquinone from naphthalene by catalytic gas phase oxidation.[108] 
Second the oxidation of 1,4-aminonaphthol, 1,4-diaminonaphthalene or 4-amino-1-
naphthalenesulfonic acid to 1,4-napthoquinone are common procedures. The catalytic 
oxidation of naphthalene is the most used and published method to receive the 
corresponding quinone. 2007 and 2010 our group reported a ruthenium catalyzed 
oxidations of naphthalene (vide supra) (Scheme 47).[80] At first we published the ruthenium 
catalyzed in a two phase system with different phase transfer catalysts (PTC). 1,4-
Naphthoquinone were obtained in 39% to 59% yield, depending on the PTC.  Next we 
published a Ru(tpy)(pydic) catalyzed one phase system and we increased the yield of the 
quinone up to  63%. In both systems we used H2O2 (30%) as oxidant. 
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Scheme 47: Ruthenium catalyzed oxidation reaction. 
 
In the literature transition metal oxidants such as chromium(VI), manganese(III), 
cobalt(III) and cerium(IV) are realized. The electrochemical recycle of these oxidants is 
also published. 1989 Kreh et al. mentioned the oxidation of naphthalene with cerium(IV) 
in methansulfonic acid to the corresponding quinone in 92% conversion and 98% 
1.8 VITAMIN K  
- 40 - 
selectivity. Additionally, after separating the product and catalyst, they regenerate Ce(III) via 
electrochemical oxidation. This oxidation procedure with electrochemical oxidation 
subsequently was patented and published in the last years.[109] Moreover electrochemical 
oxidations have been reported whereas the reaction to naphthoquinone takes place on 
electrodes.[110] The paper describes the oxidation of naphthol, which was electrolyzed in 
the presence nBu4NBF4 as supporting salts and alkenic nucleophiles using a glassy carbon 
beaker as an anode. The cathode, a platinum wire and anode are divided cell through glass 
filters. Oxidation of 4-methoxy-1-naphthol afforded two kinds of the oxidized forms, the 
anodic oxidation occurred with the one-electron oxidation of 4-methoxynaphth-1-ol to 
give the radical 4-methoxynaphthalen-1-one, followed by the second diversion of an 
electron to the cation (Scheme 48). 
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Scheme 48: Electrochemical oxidation to 1,4-naphthoquinone. 
 
Both active species might be stabilized, while the radical underwent a homogeneous 
coupling and the cation reacted with nucleophiles through the [3+2] cycloaddition reaction. 
Nevertheless this reaction system can yield 1,4-naphthoquinone up to 68% depending on 
the nucleophiles.  
 
 
1.8 Vitamin K 
The family of vitamin K includes the two naturally vitamins K1 (phylloquinone or 
phytomenadione) and K2 (menaquinone), and one synthetically produced vitamin K3 
(menadione or 2-methyl-1,4-naphthoquinone) (Figure 10).[111]  
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Figure 10: Vitamin K family. 
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All these compounds are 1,4-naphthoquinones. The methyl group at position 2 is 
responsible for the specific biological activity of vitamin K. All members of the vitamin K 
group vary in the length of the aliphatic side chain attached at the 3-postion, which 
influences the solubility and other properties. Vitamin K1 is found in plant foods, for 
example, in soybeans, milk and milk products, flesh, tomatoes, rose hips, green vegetables 
and potatoes. In contrast to that, vitamin K2 is synthesized by intestinal bacteria. Vitamin 
K1 can only reabsorb with the help of bile acid, because of the fat solubility of the vitamin 
K. Therefore, the reabsorb increase by concurrent intake of fats. In the body, vitamin K is 
in the blood plasma and is saved in liver and kidney. The hydroxylated vitamin K1 is the 
biologically active form. It acts as a cofactor for -glutamyl carboxylase and plays a crucial 
role for the  -carboxylation of coagulation proteins. Furthermore it is also involved in the 
biosynthesis of proteins in bone, kidney and plasma. Menadione (vitamin K3) is used as a 
vitamin K1 and K2 precursor and is important as food additive.[112] It shows a lower 
antihemorrhagic effect than vitamin K1 and K2. K-vitamins are able to inhibit the growth 
of many tumor cells. The mechanism of the inhibitory effect of vitamin K1 and K2 has not 
been clarified until now. Menadione shows inhibitory effects caused by alkylation of 
cellular nucleophiles damaging the cells, and by redox cycle. For this reason menadione is a 
model substrate for the application and state of the art follows.  
 
1.8.1 Application 
1.8.1.1 Antitumor effect 
Menadione inhibits the growth of tumor cells in vitro.[113] In the presence of reducing 
agents it runs a redox cycle. Menadione has a strong antitumor effect in rodent and human 
tumors, but it is also highly toxic to cells and causes side effects such as cardiotoxicity and 
anemia.[114] Cancer cells usually exhibit a poor antioxidant status,[115] thus raising the 
possibility to kill cancer cells through oxidative stress. The excessive production of reactive 
oxygen species (ROS) generates oxidative stress by quinones.  
To do that, a synergistic association of ascorbate (vitamin C) and menadione was used, it 
reacts like a one electron redox cycle (vide supra).[116] As shown in the Scheme 49, 
menadione is reduced by ascorbate to form the dehydroascorbate and the semiquinone free 
radicals.  
The semiquinone radical is rapidly reoxidized to its quinone form by molecular oxygen thus 
generating ROS. Among them hydrogen peroxide is likely the major oxidizing agent 
involved in the cytolytic process.[117] The molecular mechanisms of cell killing by 
ascorbate/menadione observed in several cell lines[118] are not totally clarified until now.  
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Scheme 49: Redox cycle of ascorbate and menadione. 
 
Nevertheless, menadione is not justifiable in the human medicine, because of its side effect. 
Also the use in the food industry is not allowed according to Federal Ministry of Health. 
Menadione is known to be mutagenic and has toxic effects in particular for liver cells. The 
application of menadione causes skin and mucous membrane irritation, allergic reactions, 
and an accumulation for eczema. High doses show symptom of poisonings with vomiting 
and albuminuria.  
  
1.8.2 State-of-the-art Synthesis 
The industrial manufacture of menadione is similarly based on the selective oxidation of an 
arene. Here, 2-methylnaphthalene is selectively oxidized to menadione (Scheme 50).  
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Scheme 50: Oxidation of 2-methylnaphthalene to the corresponding quinones. 
 
Unfortunately, the latter oxidation is still performed by using stoichiometric amounts of 
chromium trioxide in sulphuric acid. Depending on the reaction conditions product yields 
between 38–60% have been reported.[119] Due to the large amount of chromium-
containing waste, e.g. 18 kg of waste per kg of product,[119] significant research efforts 
have been made to replace this process by more environmentally benign routes. 
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As early as 1940 Arnold et al. reported the synthesis of vitamin K3 in about 30% yield by 
using hydrogen peroxide (30%) in acetic acid at 80 °C.[120] 30 years later the Mitsubishi 
Gas Chemical Co. patented an improved method for vitamin K3 synthesis using 12 eq. HCl 
and 4 eq. H2O2 (60%) in MeOH.[121] In 1985, Yamaguchi et al. reported the first metal-
catalyzed synthesis.[122] Here, the oxidation of 2-methylnaphthalene was carried out in 
acetic acid with aq. 60% H2O2 in the presence of Pd(II)-polystyrene sulfonic acid resin. At 
50 °C after 8h the conversion was 93% and 2-methyl-1,4-naphthoquinone was obtained in 
yields between 50 and 60%. The catalyst recovered by filtration was reusable. However, the 
regioselectivity of the process was not discussed in this study. Mechanistic investigations by 
the Yamaguchi group suggested a hydroxylated naphthalene intermediate before the 
quinone is formed.[123] As shown in Scheme 51, 2-methylnaphthalene is oxidized to 2-
methylnaphth-1-ol, before 2-methylnaphth-1,4-diol is formed and finally the oxidation to 
the corresponding 2-methyl-1,4-naphthoquinone takes place. 
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Scheme 51: Proposed pathway for the Pd-catalyzed oxidation of 2-methylnaphthalene. 
 
An interesting catalytic oxidation of 2-methylnaphthalene using hydrogen peroxide was 
described by Herrmann et al. in the beginning of the 1990s.[124] This reaction is catalyzed 
by methyltrioxorhenium (MTO), which is also active for several other transformations such 
as olefine metathesis or aldehyde olefination.[125] 
Applying acetic acid/acetic anhydride as solvent in the presence of catalytic amounts of 
CH3ReO3 (1 mol%), 2-methylnaphthalene is preferentially oxidized by hydrogen peroxide 
(85% in water) to the 1,4-quinone (menadione). At 40 °C and after 4 h the conversion 
amounts to 89% (quinone yield 52%). The high regioselectivity is particularly remarkable, 
favouring the isomeric 2-methylnaphthoquinones (Scheme 50), which are formed in a 7: 1 
ratio (46 % yield of menadione). From a mechanistic point of view MTO reacts with 
hydrogen peroxide to form two 2-peroxorhenium complexes, the mono-peroxorhenium 
and the di-peroxorhenium species (A and B in Scheme 52).[126] Complex B represents the 
most active catalyst for the oxidation of the substrate. To prevent MTO deactivation by 
water hydrolysis, a mixture of acetic acid and acetic anhydride with H2O2 (85% in water) is 
employed minimizing the amount of water.[127]  
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CH3
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- H2O - H2O
 
Scheme 52: Formation of the active catalyst species from MTO. 
 
In 1994, Takai and co-workers published the first catalytic system with molecular oxygen as 
oxidant.[128] By using an oxovanadium(IV)-1,3-diketone complex as a catalyst in the 
presence of molecular oxygen and crotonaldehyde, 2-methylnaphthalene was smoothly 
oxidized to the corresponding 1,4-naphthoquinone (Scheme 53). Under similar conditions 
menadione was obtained in a yield of 55%. The disadvantage of this system is the necessity 
of an auxiliary reducing agent and two equivalents of oxygen are used per oxidation taking 
place. Unfortunately, more than stoichiometric amounts of toxic crotonaldehyde have to 
be added successively. 
O
O
VO(nBuac)2 (30 mol%)
O2, MIBK, 0 °C
CHO CO2H
O
nBu
O
HnBuac =
 
Scheme 53: Oxidation of 2-methylnaphthalene with O2 and oxovanadium catalyst. 
 
The current state-of-art oxidation system for arenes to quinones was developed by W. 
Thiel and co-workers in 2006. Here, yields up to 71% of menadione are obtained.[129] 
Their reported method utilized 50% hydrogen peroxide (aq.) in a mixture of glacial acetic 
acid and acetic anhydride without any metal catalyst! Instead a strong Brønstedt acid is used 
to catalyze the reaction. Different acids such as perchloric acid, phosphorus acid or sulfuric 
acid have been applied as catalysts. The observed ratio of regioisomers is approximately 
8:1. From a mechanistic perspective two possible reaction paths were considered (Scheme 
54).  
On the one hand, initial epoxidation and subsequent rearrangement leads to the target 
molecules (I). On the other hand, protonation and acylation of the arene gives the mono-
hydroxylated derivative (II). Notably, the hydroxylated intermediate was detected by gas 
chromatography.  
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I: Epoxidation pathway 
O
O
OH
OH
O
O
CH3CO3H2 CH3CO3H
 
II: Electrophilic aromatic substitution pathway 
O OH
CH3CO3H2+
H O
O O
+ H2O
OH
OH
O
O
- H2O - H
+
- AcOH
 
Scheme 54: Possible reaction pathways towards vitamin K3  according to Thiel and co-workers. 
 
In our previous investigations a practical ruthenium phase-transfer catalyst (Ru-PTC) 
system for the oxidation of 2-methylnaphthalene has been developed.[80a),b)] We used a 
ruthenium catalyst  in water without the addition of any organic solvent and acid and 
different phase transfer catalysts (Scheme 55). Yields of 64% and a combined selectivity 
towards the 1,4-quinone products of 73% were reported. The main drawback of this 
method remains the low product ratio of 3:1 between 2-methyl-1,4-naphthoquinone and 6-
methyl-1,4-naphthoquinone, and the incomplete conversion of the starting material.  
N
N N
N
O
O
O
O
Ru
N
+
Cl-
10 SO3Na
Scheme 55: Ru(tpy)(pydic)-catalyst and phase transfer catalysts employed for vitamin-K3 synthesis. 
 
To solve this problem we performed a solvent screening and were able to develop a one 
phase system with methanol as solvent. However, we published an environmentally benign 
method for the oxidation of 2-methylnaphthalene to vitamin K3 in a one-phase system with 
a maximum yield of 62% and a ratio between the two regioisomers of 5:1. Only 3.2 
equivalents H2O2 and a low catalyst loading of 1 mol% are required.  
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By applying the optimized conditions the feed additive menadione (vitamin K3) is obtained 
from 2-methylnaphthalene with 64% yield and 73% selectivity. 
Due to their interesting redox chemistry and easy availability also iron-based catalysts have 
been applied for the synthesis of quinones from arenes. The first example was published in 
1997 by Meunier and co-workers, who described an iron-porphyrin catalyzed oxidation of 
2-methylnaphthalene. The reported system makes use of a sulfonated porphyrin, allowing 
the catalyst to be water-soluble (Figure 11).[130] Unfortunately, potassium 
peroxomonosulfate had to be used as oxidant and vitamin K3 is obtained only in moderate 
44% yield due to the low regioselectivity of the oxidation. A different iron catalyst system 
utilized tetrasulfonic phthalocyanine (FePcS) immobilized on silica (Figure 11).[131] 
Sorokin et al. reported that the FePcS’s are bound together to form an active dimer. The 
reaction was run in acetonitrile using 4 mol% of the catalyst and t-BuOOH as oxidant 
providing quinones and vitamin K3 in yields of 65% and 45%, respectively.  
N
N
N
N
R R
RR
Fe R =
H3C SO3H
CH3
SO3HH3C
Porphyrincomplex
N
N N
N
NaSO3
SO3Na
SO3Na
NaSO3
Fe
Phthalocyanincomplex  
Figure 11: Iron-porphyrin- and phthalocyanin complexes for arene oxidations. 
 
Most recently, we described an efficient oxidation of 2-methylnaphthalen using easily 
available iron complexes.[132] We applied a simple and green in situ system FeCl3·6H2O, 
pyridine-2,6-dicarboxylic acid (H2Pydic) and benzylamine ligands with hydrogen peroxide 
(30%). Applying an acetonitrile/water mixture the desired quinone (menadione) is obtained 
in 44% yield. However, the ratio between the two regioisomers (Scheme 50) is 3:1.  
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1.9. Vitamin E 
Vitamin E is the collective name / denotation of all tocopherols and tocopherol derivatives 
having the biological activity of RRR--tocopherol (the only stereoisomere occurred in 
nature). There are four different tocopherols (Figure 12) that differ in the number and 
position of methyl groups on the chromanol head.  
O
HO
R3
R2
R1
vitamin E
-tocopherol: R1=R2=R3=CH3
-tocopherol: R1=R3=CH3; R2=H
-tocopherol: R1=R2=CH3; R3=H
-tocopherol: R1=CH3; R2=R3=H
 
Figure 12: Tocopherol derivates. 
 
However the isoprenic side chain is the same.[133] Vitamin E is a fat soluble vitamin 
present in many foods, especially certain fats and oil. Due to their high antioxidant 
activity,[134] tocopherols have been used in medications, health-care and cosmetic 
formulations and as stabilizers in plastic packing.[135, 136] They help to protect the body 
against the formation of free radicals, effects of pollution and other toxins, it helps 
premature aging, cancer and other chronic, degenerative diseases. Vitamin E even protects 
other nutrients from damage. The immune system is dependent upon this vitamin for 
strength and stability. Adequate vitamin E is needed to heal injured tissues and prevent 
scarring. 
 
1.9.1. Application 
1.9.1.1 Antioxidants 
Oxygen is responsible for the destroying of biomolecules. The result of the reaction 
cascade is the biochemical reduction of O2 to water. During this reaction four electrons 
and four protons were absorbed (Scheme 56) 
OHeHO 22 244 

Scheme 56: Reduction of O2 to water. 
 
Some compounds were synthesized during this reaction, for example the superoxide O2- 
and the hydroxyl radical OH.. These compounds are responsible for the reaction of the 
chain growth. It is suspected, that processes like these are involved into the development 
of emphysema, arterioscleroses, several chronically inflammation, cancer und aging 
processes. A huge number of natural antioxidants inhibit this oxidative permutation and 
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protect the lipid molecule of the cell membrane. The tocopherol-anion is an electron donor 
and can stop the reaction cascade of the lipid oxidation by reduction to a radical product. 
After that the lipid radical was protonated and the vitamin E oxidized to a radical, followed 
be the recycling of vitamin E on the membrane surface with water soluble vitamin C 
(Scheme 57).  
O
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R
HO
O R
Lipide-O
or
Lipide-O-O
O O
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HO
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Lipide-O-OH
O O
OHHO
HO
HO
Ascorbate
H
 
Scheme 57: Redox cycle of -tocopherol and ascorbate. 
 
Vitamin E possesses some anticoagulant activity to prevent the formation of blood clots. 
The natural form of vitamin E D-alpha tocopherol is highly superior to the synthetic form 
known as DL- tocopherol. Only the natural D- tocopherol is used in Vitamin E cream, 
which will be absorbed through the skin cells into the bloodstream, nourishing the skin 
inside and outside.[137] 
 
1.9.2. State-of-the-art Synthesis 
The well known reaction of -tocopherol is shown in Scheme 58. The main key of this 
synthesis is the production of trimethylbenzoquinone (TMBQ). Thereby we focus on the 
synthesis of this compound. Two starting material are possible to obtain TMBQ in high 
yield. One is 1,3,4-trimethylbenzene (TMB) and the second is  2,3,6-trimethylphenol 
(TMP) (Scheme 58 & 59). 
OH O
O
OH
OH
vitamin Eisophytol
TMB TMP TMBQ  
Scheme 58: Reaction of vitamin E. 
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To date several protocols have been established for the direct oxidation of TMP to 
TMBQ,[138] however only few of them are of industrial relevance. 
In the technical process of TMP a CuCl2-mediated oxidation with oxygen is used in the 
presence of lithium chloride. Applying a biphasic solvent of water and an aliphatic alcohol 
yields of up to 98% can be achieved.[139] Unfortunately, stoichiometric amounts of copper 
are applied under these conditions. This results in large amounts of copper waste and 
product contamination. Thus, the development of more environmentally friendly 
procedures for the oxidation of TMBQ is also of actual interest.  
Regarding the direct oxidation of TMP to TMBQ the work of Schuster et al. is noteworthy. 
They reported that Salcomin (a salencobalt(II) complex) (Figure 13) catalyzed this 
oxidation under oxygen atmosphere to the corresponding quinone in 80–95% yield at 45 
°C within 1h.[140]  
O
N N
O
Co
Salcomin  
Figure 13: Salcomin catalyst for oxidation of TMP to TMBQ. 
 
An industrial process developed by Shimizu et al. for this oxidation is performed in the 
presence of heteropolyacids. Apparently, the process is run in a two-phase solvent system 
of acetic acid and a non-polar solvent such as dichloromethane. As oxidizing agents both 
oxygen and hydrogen peroxide have been used. The yields for TMBQ achieved are in 
between 70% and 85%.[141] Another industrially applied method for the synthesis of 
TMBQ is based on the use of copper (II)-chloride. Attempts to reduce the stoichiometric 
amounts of copper salts, led to a catalyst system consisting of CuCl2 (1.5 wt%) and 
hydroxylamine hydrochloride (2.8 wt%) as an additive. Reactions of TMP performed in 
acetic acid resulted in a yield of 80% of TMBQ. However, the disadvantage of this system 
is the use of t-BuOOH as a terminal oxidant. Conversion and yield of TMBQ using oxygen 
are low.[138d)] Already in 1983, the Ito group developed a Ru-catalyzed reaction of TMP 
in acetic acid as solvent.[138b)] In the presence of 1 mol% RuCl3 and two equivalents H2O2 
yields up to 90% of the desired quinine were achieved. Until to date this is still amongst the 
most effective catalytic processes; however there is no application in industry due to the 
high price of the catalyst. During the last years also a novel heterogeneous Ti(IV)/SiO2-
catalyst was developed by Kholdeeva et al.[138e)] Here, the oxidation of TMP with H2O2 
in acetonitrile at 80 °C proceeded in yields up to 96%.[138f)]  
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In literature an iron catalyst system utilized tetrasulfonic phthalocyanine (FePcS) 
immobilized on silica (Figure 11) is also known for the synthesis of TMP to TMBQ.[142] 
Sorokin et al. reported that the FePcS’s are bound together to form an active dimer. The 
reaction was run in acetonitrile using 4 mol% of the catalyst and t-BuOOH as oxidant 
providing quinones and TMBQ was obtained in yields up to 79%. 
Most recently, we described an efficient oxidation of TMP using easily available iron 
complexes (FeCl3·6H2O/H2Pydic/n-butylbenzylamine) with hydrogen peroxide (30%) at 0 
°C.[132] Applying an acetonitrile/water mixture the desired quinone is obtained in 89% 
yield. Closely related to the iron-catalyzed system an improved one phase system relying on 
a ruthenium(2,2’,6’:2”-terpyridine)(2,6-pyridinedicarboxylate) catalyst was developed.[80c)] 
With this catalyst system we obtained TMBQ in 83% yield after 1.5h. 
An economically interesting alternative synthesis of TMBQ is based on the potential 
oxidation of 1,3,4-trimethylbenzene (TMB) (Scheme 59). 
O
O
TMB TMBQ
Scheme 59: Oxidation of TMB to TMBQ. 
 
So far, this straightforward oxidation has been scarcely reported in the open literature. 
Although Scheme 60 a process for the conversion of TMB to TMBQ is shown that has 
been used even on industrial scale. Unfortunately, it needed several steps before the final 
quinone is generated (Scheme 60).  
HO3S HO3S
NO2
NO2
NH2
NH2
O
O
H2SO4 H2SO4
KNO3
Sn, HCl CrO3
 
Scheme 60: Multistep synthesis of TMBQ from TMB. 
 
Initially, TMB is sulfonated in the 5-position blocking it from the following nitration of the 
remaining aromatic positions. Subsequent reduction of the nitro groups and cleavage of the 
sulfonic acid are realized using stoichiometric amounts of tin in hydrochloric acid. Finally, 
oxidation by chromium (VI)-oxide gives the target compound resulting in an overall yield 
of 30%.[143] The disadvantages of this method is the four step linear synthesis as well as 
large amounts of waste including the highly toxic tin-and chromium compounds. 
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Obviously, the challenge for this substrate is the direct oxidation with benign oxidants. 
However, such processes have been described in literature only with moderate success, e.g. 
the oxidation of TMB by organic peracids in dichloromethane resulted in yields of up to 
15%.[138a)] By-products in this reaction are 2,3,6-trimethylphenol and 2,4,5-
trimethylphenol. Oxidation with H2O2 in formic acid was reported by Takehira et al. in 
1989 and is more environmentally friendly; however the achieved yield is also low with 
16%.[138c)] In general, these single-step procedures showed either low conversions and/or 
low selectivities to the desired product. Analogous to their MTO-catalyzed oxidation of 2-
methylnaphthalene, Jacob et al. reported the reaction of TMB to TMBQ, too.[144] The 
reaction was run with 8 mol% MTO and a 20-fold excess of 30% H2O2. After 75% 
conversion a yield of 50% of TMBQ was obtained. In addition, the corresponding 
hydroquinone was generated with up to 25%.  
Our group was also interested in this reaction. Thereby is possible to use the published iron 
system (vide supra) for the oxidation of TMP to TMBQ. We achieved the corresponding 
quinone in 69% conversion and 38% selectivity.. 
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1.10 Conclusion 
 
In summary, it has been demonstrated that quinones are versatile in occurs as well as 
applications. Therefore the development of isolation or rather syntheses of these 
compounds are important. Thereby the oxidation to vitamin K3 and TMBQ a vitamin E 
precursor were our main focus in this dissertation (Scheme 61 and 62). 
A drawback of most arene oxidations to quinones is the use of acidic solvents, i.e. acetic 
acid, or the necessity to add inorganic acid catalysts causing environmental pollution and 
carrying corrosion issues with it, especially on larger scale. In general, high concentrations 
of hydrogen peroxide (50-83%) are needed in order to achieve acceptable yields of 
menadione or TMBQ from its aromatic precursors.[127,145] Due to the explosive nature 
of highly concentrated hydrogen peroxide, especially in combination with metal salts, this 
may cause severe safety problems.[129] Thus, the development of more environmentally 
friendly procedures for the oxidation of these quinones is of actual interest.  
[Cat.]
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O
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Scheme 61: Oxidation of 2-methylnaphthalene to its corresponding quinones. 
 
Recently it has been demonstrated that high activity and even excellent chemoselectivity 
can be achieved in Ru- and Fe-catalyzed oxidation of naphthalene derivatives and 
monohydroxylated arenes to the corresponding quinones with hydrogen peroxide.[80,132] 
The choice of catalyst was next to the oxidant the challenging goal for these oxidation 
reactions. Requirements for modern oxidation methods include cheap and selective 
catalysts, high atom efficiency, as well as environmentally friendly oxidants. On the basis of 
atom economy and environmental considerations, hydrogen peroxide and molecular 
oxygen, are the most desirable oxidants.  
[Cat.]
H2O2
O
O
OH
Scheme 62: Oxidation of TMP to TMBQ. 
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The ruthenium catalyzed process generated an environmentally benign method for the 
oxidation of 2-methylnaphthalene to vitamin K3 in a one-phase system with a maximum 
yield of 62% and a ratio of 5:1 between the two regioisomers. Only 3.2 equivalents H2O2 
and a low catalyst loading of 1 mol% are required. However the first iron-catalyzed 
oxidation of phenols and arenes to 1,4-quinones has been developed. Applying the 
inexpensive and practical catalyst system consisting of iron trichloride hexahydrate, 
pyridine-2,6-dicarboxylic acid, and benzylamine derivatives industrially important 
oxidations of TMP and 2-methylnaphthalene took place in 79% and 55% yield, 
respectively. 
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2. Objects of this work 
 
 There is a continuing interest in the development of improved methods for the 
synthesis of quinones, owing to their importance in nature, agriculture, medicine and 
industry. Therefore the development of novel and improved methods for their synthesis is 
important. Our group has a significant experience on the use of homogenous catalysts for 
various oxidation reactions, which provided the basis for the present work.   
 The starting point of this thesis constituted the use of the known ruthenium 
(2,2’,6’:2”-terpyridine)(2,6-pyridinedicarboxylate) catalyst (chapter 3.1, publication Adv. 
Synth.Catal. 2010) in the oxidation of naphthalene derivatives and monohydroxylated arenes 
to give the corresponding quinones. Herein, we developed an environmentally benign 
method for the oxidation of arenes to the corresponding quinones, e.g. 2-
methylnaphthalene to vitamin K3 or TMP to TMBQ, in a one-phase system. Based on 
former experiments,[80a)-b)] it was possible to improve yields and regioselectivity by using 
only 3.2 equivalents H2O2 and a low catalyst loading of 1 mol%.  
Based on these promising results and our experience in iron-catalyzed oxidations, 
we were intrigued if an iron catalyst is also feasible for this transformation. Obviously, such 
iron-catalysts are desirable due to their lower toxicity and common availability. Indeed, we 
succeeded in the first iron-catalyzed oxidation of phenols and arenes to 1,4-quinones under 
mild conditions (chapter 3.2, publication Chem. Eur. J. 2010). Our studies showed that an in 
situ generated iron complex (FeCl3.6H2O/H2Pydic/benzylamine) is a viable catalyst to 
perform this reaction efficiently using hydrogen peroxide as a terminal oxidant. The newly 
developed catalyst is able to fully convert naphthalene derivatives and monohydroxylated 
arenes to the desired products in high yields and selectivities. Table 3 gives an overview of 
selected oxidation results applying either the ruthenium or the iron catalyst system. 
Table 3: Selected results in arene hydroxylation from our group. 
Substrate Product Ru-system Fe-system 
 
O
O  
>99% conv. 
63% select.
- 
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Substrate Product Ru-system Fe-system 
 
O
O
>99% conv. 
39% select.
- 
 
>99% conv. 
34% select.
- 
 
>99% conv.
62% select.
>99% conv. 
55% select. 
OH
 
O
O  
>99% conv.
78% select.
>99% conv. 
55% select 
OH
 
>99% conv.
83% select.
>99% conv. 
79% select 
 
O
O  - 
>99% conv. 
38% select 
 
Most recently, we published a detailed study and an overview of recent quinone synthesis, 
including the synthesis of vitamin K3 and TMBQ, which is shown in chapter 3.3, 
publication Catal. Today 2011. Thereby we focused on the use of environmental friendly 
oxidants like molecular oxygen or hydrogen peroxide.  
 
 Based on our iron catalyzed oxidation to quinones we developed also the oxidation 
of alcohols to aldehydes as well as ketones in the presence of iron complexes (chapter 3.4, 
publication Adv. Synth. Catal. 2011) (Scheme 63). Based on our experience in iron catalyzed 
oxidations of arenes[132] and epoxidation we were asked ourselves if these systems would 
be feasible for alcohol oxidations, too.  
R1 OH R1 O
R2 R2
 H2O2
[Fe]
 
Scheme 63: Oxidation of an alcohol to the corresponding aldehyde or ketone. 
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While for arene oxidations H2Pydic turned out to be a suitable ligand, for epoxidation 
imidazole ligands were useful. For the first time we combined the two ligand systems and 
created a novel iron-catalyst (FeCl2/L/Na2CO3) (Figure 14).  
 
Figure 14: Ligands for arene oxidation, epoxidation and alcohol oxidation. 
 
More specifically, we reported a novel iron-catalyzed oxidation of benzylic and 
allylic alcohols using hydrogen peroxide as oxidant under air and mild conditions. The 
developed method is applicable to a broad range of substrates. Good to excellent 
chemoselectivity for the oxo-product is demonstrated using substituted benzyl alcohols as 
well as sensitive substrates like terpenoidal alcohols. The various products have been 
synthesised in 48-95% yields and 58-99% selectivity. Mechanistic investigations (X-Ray 
analysis and ESI-MS measurements) have also been performed. 
Next, we were also interested in non-chiral and and asymmetric epoxidations. In 
this respect, we developed a methyltrioxorhenium (MTO)-catalyzed epoxidation of olefins 
with hydrogen peroxide as the oxidant in the presence of non-chiral or chiral ligands 
(chapter 3.5, publication J. Organom. Catal. 2011). Initially, we studied the epoxidation of 1-
octene with chiral (oxazoline and pybox) and non-chiral ligands, which proceeded with 
excellent chemoselectivities (>90%) (Scheme 64).  
3 mol%MTO
12 mol%Ligand
2equiv. H2O2 (30%)
CH2Cl2, r.t.
O
 
Scheme 64: Oxidation of 1-octene. 
 
Depending on the ligand the activity of the catalyst was not influenced or inhibited 
or at best increased. By NMR measurements the reactivity of different oxazoline and pybox 
ligands could be explained. For example, electronic properties of the ligands determine the 
activity in the MTO-catalyzed epoxidation of olefins while steric factors have a negligible 
influence. In addition, the asymmetric oxidation of olefins with MTO and chiral ligands 
was investigated. This problem constitutes a long standing goal in asymmetric oxidations. 
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We achieved excellent chemoselectivities and up to 19% ee with several pybox ligands or its 
precursor (Table 4).  
Table 4: Selected results in olefin oxidation with chiral ligands. 
Ligand Olefin 
Conv. 
[%] 
Select 
[%] 
ee 
[%] 
 
86 100 18 
 
53 100 11 
 
 
81 92 11 
 
100 100 18 
  
100 88 11 
 
Furthermore we succeeded in a novel X-Ray structure of one of the pybox ligands 
(chapter 3.6, publication Acta. Cryst. E 2011) illustrating the spatial arrangement of this 
compound. 
 Parallel to the work on catalytic oxidations, also catalytic reduction reactions like 
hydrosilylation of carbonyl compounds in the presence of zinc catalysts were studied. Due 
to its abundant availability, low toxicity and biomimetic nature zinc proves to be a highly 
attractive candidate for catalysis. On one side we were interested in the asymmetric 
transformation of ketones to secondary alcohols by using pybox ligands (chapter 3.7, 
publication Chem. Asien J. 2011) and on the other side on the chemoselective reduction of 
esters to alcohols (Chem Eur. J. 2011). 
 The asymmetric reaction of ketones to secondary alcohols represents an efficient 
approach for the preparation of chiral alcohols which are used as versatile building blocks 
for pharmaceuticals, agrochemicals, flavours and fragrances. We developed a simple in situ 
catalyst composed of ZnEt2, commercially available pybox ligands and inexpensive 
polymethylhydrosiloxane (PMHS) as reductant (Scheme 65).  
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*
ZnEt2/L, 
5 equiv. PMHS
THF, 20 h, r.t.
MeOH
NaOH
N
N
O
N
O
R3 R3L =
26 examples
up to 73% ee
 
Scheme 65: Reduction of ketones to second chiral alcohols. 
 
Enantioselective zinc-catalysed asymmetric hydrosilylations of carbonyl compounds were 
achieved under mild conditions with high yields and good enantioselectivities for a broad 
range of aryl alkyl, cyclic, heterocyclic and aliphatic ketones. In addition ESI measurements 
have been performed to characterize the active catalyst. 
 Furthermore, a general and chemoselective catalytic reduction of esters to alcohols 
using inexpensive zinc acetate and (EtO)2MeSiH has been developed. A variety of esters, 
including aromatic, aliphatic, heteroaromatic, and heterocyclic esters were reduced 
smoothly to the corresponding alcohols (Scheme 66). 
R1 O
O
R2
10 mol%Zn(OAc)2
(EtO)2MeSiH, 65 °C, 24h R1 OH
R1=Aryl, R2= Alkyl
Scheme 66: Reduction of ester to alcohol. 
 
After demonstrating the general applicability, we were interested in the functional group 
tolerance of our catalytic system. Hence, we studied the reactivity of more challenging 
substrates that might undergo additional reductive transformations. Such chemoselective 
reductions of esters are particularly interesting for the organic synthesis of multifunctional 
molecules. The operational simplicity and the high functional group tolerance, without the 
need for protecting and deprotecting steps, make this procedure particularly attractive for 
organic synthesis 
.
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